HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,421,738 | +31.7% | 20,933 | +17.1% | 0.01% | +60.0% |
| Q2 2023 | $1,839,164 | -11.0% | 17,882 | -5.5% | 0.01% | -16.7% |
| Q1 2023 | $2,065,365 | -18.2% | 18,924 | -14.7% | 0.01% | -33.3% |
| Q4 2022 | $2,523,970 | +77.0% | 22,179 | -3.8% | 0.01% | +80.0% |
| Q3 2022 | $1,426,000 | -17.5% | 23,049 | +6.4% | 0.01% | -16.7% |
| Q2 2022 | $1,728,000 | -42.7% | 21,666 | -24.4% | 0.01% | 0.0% |
| Q1 2022 | $3,015,000 | -25.7% | 28,662 | -23.8% | 0.01% | -25.0% |
| Q4 2021 | $4,056,000 | -30.9% | 37,637 | -29.8% | 0.01% | -50.0% |
| Q3 2021 | $5,872,000 | +29.3% | 53,606 | +10.5% | 0.02% | +23.1% |
| Q2 2021 | $4,543,000 | +40.2% | 48,511 | +37.8% | 0.01% | +30.0% |
| Q1 2021 | $3,240,000 | +16.5% | 35,201 | -7.4% | 0.01% | 0.0% |
| Q4 2020 | $2,782,000 | -7.8% | 38,026 | -2.1% | 0.01% | -28.6% |
| Q3 2020 | $3,016,000 | +61.7% | 38,829 | +15.7% | 0.01% | +40.0% |
| Q2 2020 | $1,865,000 | +115.6% | 33,564 | +14.9% | 0.01% | +66.7% |
| Q1 2020 | $865,000 | -46.9% | 29,213 | -35.1% | 0.01% | -25.0% |
| Q4 2019 | $1,629,000 | +9.0% | 44,991 | -18.0% | 0.01% | 0.0% |
| Q3 2019 | $1,494,000 | -20.0% | 54,853 | -29.4% | 0.01% | -27.3% |
| Q2 2019 | $1,868,000 | – | 77,645 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |